These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1153 related articles for article (PubMed ID: 16829981)

  • 1. EGF-ERBB signalling: towards the systems level.
    Citri A; Yarden Y
    Nat Rev Mol Cell Biol; 2006 Jul; 7(7):505-16. PubMed ID: 16829981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
    van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ
    J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding specificities and affinities of egf domains for ErbB receptors.
    Jones JT; Akita RW; Sliwkowski MX
    FEBS Lett; 1999 Mar; 447(2-3):227-31. PubMed ID: 10214951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity within the EGF family/ErbB receptor family signaling network.
    Riese DJ; Stern DF
    Bioessays; 1998 Jan; 20(1):41-8. PubMed ID: 9504046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology.
    Eccles SA
    Int J Dev Biol; 2011; 55(7-9):685-96. PubMed ID: 22161825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
    McManus MJ; Boerner JL; Danielsen AJ; Wang Z; Matsumura F; Maihle NJ
    J Biol Chem; 2000 Nov; 275(45):35328-34. PubMed ID: 10954714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.
    Burgess AW; Cho HS; Eigenbrot C; Ferguson KM; Garrett TP; Leahy DJ; Lemmon MA; Sliwkowski MX; Ward CW; Yokoyama S
    Mol Cell; 2003 Sep; 12(3):541-52. PubMed ID: 14527402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.
    Lidke DS; Nagy P; Heintzmann R; Arndt-Jovin DJ; Post JN; Grecco HE; Jares-Erijman EA; Jovin TM
    Nat Biotechnol; 2004 Feb; 22(2):198-203. PubMed ID: 14704683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk.
    El Sheikh SS; Domin J; Abel P; Stamp G; Lalani el-N
    Neoplasia; 2003; 5(2):99-109. PubMed ID: 12659682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention.
    Citri A; Kochupurakkal BS; Yarden Y
    Cell Cycle; 2004 Jan; 3(1):51-60. PubMed ID: 14657666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
    Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
    Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype.
    Ballarò C; Ceccarelli S; Tiveron C; Tatangelo L; Salvatore AM; Segatto O; Alemà S
    EMBO Rep; 2005 Aug; 6(8):755-61. PubMed ID: 16007071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF receptor.
    Wells A
    Int J Biochem Cell Biol; 1999 Jun; 31(6):637-43. PubMed ID: 10404636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology using engineering tools: the negative feedback amplifier.
    Birtwistle MR; Kolch W
    Cell Cycle; 2011 Jul; 10(13):2069-76. PubMed ID: 21572255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma.
    Roesler R; Souza BK; Isolan GR
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB receptors: new insights on mechanisms and biology.
    Linggi B; Carpenter G
    Trends Cell Biol; 2006 Dec; 16(12):649-56. PubMed ID: 17085050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of c-erbB family oncogenes in head and neck cancer.
    Rogers SJ; Harrington KJ; Rhys-Evans P; O-Charoenrat P; Eccles SA
    Cancer Metastasis Rev; 2005 Jan; 24(1):47-69. PubMed ID: 15785872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.
    Frank SJ
    J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):119-29. PubMed ID: 18236142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.
    Redemann N; Holzmann B; von Rüden T; Wagner EF; Schlessinger J; Ullrich A
    Mol Cell Biol; 1992 Feb; 12(2):491-8. PubMed ID: 1346334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on "EGF receptor downregulation depends on a trafficking motif in the distal tyrosine kinase domain".
    Hamm-Alvarez SF
    Am J Physiol Cell Physiol; 2002 Mar; 282(3):C417-9. PubMed ID: 11832326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 58.